BarrySGeorgeMDBE,FACC,FSCAI,FACP,DD(he/him)

PubMed

• 60 citations
  Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.
  Nicolas M Van Mieghem, G Michael Deeb, Lars Søndergaard, Eberhard Grube, Stephan Windecker
  JAMA Cardiology. 2022-10-01
• 13 citations
  Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease
  Juan A. Crestanello, Jeffrey J. Popma, David H. Adams, G. Michael Deeb, Mubashir Mumtaz
  JACC. Cardiovascular Interventions. 2017-11-27
• 4 citations
  Perioperative Management of Dual-Antiplatelet Therapy in Patients With New-Generation Drug-Eluting Metallic Stents and Bioresorbable Vascular Scaffolds Undergoing Elec...
  Michael Essandoh, Adam A. Dalia, Mazen Albaghdadi, Barry George, Nicoleta Stoicea
  Journal of Cardiothoracic and Vascular Anesthesia. 2017-10-01

Journal Articles

• Distal Embolic Protection---Don’t Cause a Stroke Trying to Prevent One!  
  George, BS, The Journal of Invasive Cardiology, 9/1/2005
• Cutting Balloon Angioplasty of the Popliteal and Infrapopliteal Vessels for Symptomatic Limb Ischemia  
  Ansel GM, SampleNS, Botti CF, Tracey AJ, Silver MJ, Marshall BJ, George BS, Catheterization and Cardiovascular Interventions, 1/1/2004
• Abciximab Readministration: Results of the ReoPro Readministration Registry  
  Tcheng JE, Kereiakes DJ, Lincoff AM, George BS, Kleiman NS, Sane DC, Cines DB, Jordan RE, Mascelli MA, Langrall MA, Damaraju L, Schantz A, Effron MB, Braden GA for Reo..., Circulation, 8/21/2001
• Why Endovascular Therapy should be Utilized before Surgical Bypass for Femoropopliteal Occlusive Disease  
  Ansel GM, Botti CF, Silver MJ, George BS, The Journal of Invasive Cardiology, 8/1/2001
• Infrapopliteal Endovascular Techniques: Indications, Techniques, and Results  
  Ansel G, George B, Botti C, Silver M, Current Interventional Cardiology Reports, 5/1/2001
• Rheolytic Thrombectomy During Percutaneous Revascularization for Acute Myocardial Infarction: Experience with the Angiojet Catheter  
  Silva JA, Ramee SR, Cohen DJ, Carrozza JP, Popma JJ, Lansky AA, Dandreo K, Baim DS, George BS, McCormick DJ, Setum CM, Kintz RE, Am Heart Journal, 3/1/2001
• Combined coronary and peripheral intervention: The oculo-stenotic-dilatory medicine?  
  George BS, Catheter Cardiovasc Interv, 1/1/2001
• Percutaneous radial approach: Isn’t it time we put it in its place?  
  George BS, The Journal of Invasive Cardiology, 6/1/2000
• Percutaneous Iliac Arterial Intervention: Current Indications, Results, and Techniques  
  Ansel GM, George BS, Botti CF, Current Interv Cardiol Rep, 12/1/1999
• Modifiable risk factors for vascular access site complications in the IMPACT angioplasty with versus without epitibatide Integrilin to Minimize Platelet Coronary Thro...  
  Mandak JS, Blankenship JC, Garner LH, Berkowitz SD, Aguirre FV, Sigmon KN, Timmis, Gilchrist IC, McIvorM, Resar J, Weiner BH, George BS, Talley JD, Lincoff AM, Tcheng ..., J Am Coll Cardiol, 6/1/1998
• Efficacy and Safety of Cutting Balloon in Small Coronary Arteries (<275 mm): A Report from the Cutting Balloon Global Randomized Trial  
  Bassand JPL, Weiner BH, McFadden EP, Knopf WD, Slagboom T, Adelman AG, Rees AP, Hanet C, Danchin N, Peters TF, George BS, Bonan JR, American Heart Association Supplement to Circulation, 10/1/1997
• Clinical Characteristic and Long-Term Outcome of Patients in Whom Congestion develops after Thrombolytic Therapy for Acute Mocardial Infarction: Develop Predictive Model  
  O’Connor CM, Hathaway WR, Bates ER, Leimberger JD, Sigmon KN, Keriakes DJ, George BS, Smaha JL, Abbottsmith CW, Candela RJ, Topol EJ, Califf RM, Am Heart J, 6/1/1997
• Economic Implications of the Prophylactic Use of Intraaortic Balloon Counter Setting of Acute Myocardial Infarction The Randomized IABP Study Group Balloon Pump  
  Talley JD, Ohman EM, Mark DB, George BS, Leimberger JD, Berdan LG, Davidson-Ray L, Rawert M, Lam LC, Phillips HR, Califf RM, Am J Cardiol, 3/1/1997
• Theoretical and Clinical Aspects of Slow Flow and No-Reflow Phenomenon  
  George BS, J Invasive Cardiol, 1/1/1996
• Frequency, Significance, and Cost of Recurrent Ischemia after Thrombolytic Therapy for Acute Myocardial Infarction A TAMI Study  
  Barbagelata A, Granger CB, Topol EJ, Worley SJ, Kereiakes DJ, George BS, Ohman EM, Leimberger JD, Mark DB, Califf RM, American Journal of Cardiology, 11/15/1995
• Creatine Kinase MM and MB Isoforms in Patients Receiving Thrombolytic Therapy and Acute Angiography TAMI Study Group  
  Christenson RH, Ohman EM, Topol EJ, O’Hanesian MA, Sigmon KN, Duh SH, Kereiakes DJ, Worley SJ, George BS, Pizzo CK, et al, Clinical Chemistry, 6/1/1995
• Effect of Cigarette Smoking on Outcome after Thrombolytic Therapy for Myocardial Infarction  
  Grimes CL, Topol EJ, O’Neill WW, George BS, Kereiakes D, Phillips HR, Leimberger JD, Woodlief LH, Califf RM, Circulation, 1/15/1995
• TEC for Old Grafts, TEC for New Clots: If you don’t like it, You’re not using it right  
  George BS, J Invasive Cardiol, 1/1/1995
• Adjunctive Thrombolytic Agents with Coronary Interventional Techniques [Review] [65 refs]  
  Yakubov SJ, George BS, Chapekis AT, Cardiology Clinics, 11/1/1994
• Pharmacodynamics of Chimeric Glycoprotein llb/llla Integrin Antiplatelet Antibody Fab 7E3 in High-Risk Coronary Angioplasty  
  Tcheng JE, Ellis SG, George BS, Kereiakes DJ, Kleiman NS, Talley JD, Wang AL, Weisman HF, Califf RM, Topol EJ, Circulation, 10/1/1994
• Use of Aortic Counterpulsation to Improve Sustained Coronary Artery Patency During Acute Myocardial Infarction Results of a Randomized Trial, The Randomized IABP Stud...  
  Ohman EM, George BS, White CJ, Kern MJ, Gurbel PA, Freedman RJ, Lundergan C, Hartman JR, Talley JD, Frey MJ, et al, Circulation, 8/1/1994
• Randomized Evaluation of Coronary Angioplasty for Early TIMI 2 Flow after Thrombolytic Therapy for the Treatment of Acute Myocardial Infarction: A New Look at an Old ...  
  Ellis SG, Lincoff AM, George BS, Kereiakes DJ, Ohman EM, Krucoff MW, Califf RM, Topol EJ, Coronary Artery Disease, 7/1/1994
• Recombinant Human Superoxide Dismutase (h-SOD) Fails to Improve Recovery of Ventricular Function in Patients Undergoing Coronary Angioplasty for Acute Myocardial Infar...  
  Flaherty JT, Pitt B, Grubert JW, Heuser RR, Rothbaum DA, Burwell LR, George BS, Kereiakes DJ, Deitchman D, Gustafson N, et al, Circulation, 5/1/1994
• Randomized Trial of Coronary Intervention with Antibody Against Platelet llb/llla Integrin for Reduction of Clinical Restenosis: Results at Six Months The EPIC Invest...  
  Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, et al, Lancet, 4/4/1994
• An Analysis of the Cause of Early Mortality after Administration of Thrombolytic Therapy The Thrombolysis and Angioplasty in Myocardial Infarction Study Group  
  Ohman EM, Topol EJ, Califf RM, Bates ER, Ellis SG, Kereiakes DJ, George BS, Samaha JK, Kline E, Sigmon KN, et al, Coronary Artery Disease, 11/1/1993
• Join now to see all